| | 209335-49-9 Basic information More.. |
| Product Name: | feglymycin | | Synonyms: | feglymycin;L-Aspartic acid, (2R)-2-(4-hydroxyphenyl)glycyl-(2R)-2-(3,5-dihydroxyphenyl)glycyl-L-valyl-(2R)-2-(3,5-dihydroxyphenyl)glycyl-(2S)-2-(4-hydroxyphenyl)glycyl-(2R)-2-(3,5-dihydroxyphenyl)glycyl-(2S)-2-(4-hydroxyphenyl)glycyl-(2R)-2-(3,5-dihydroxyphenyl)glycyl-L-valyl-(2R)-2-(3,5-dihydroxyphenyl)glycyl... | | CAS: | 209335-49-9 | | MF: | C95H97N13O30 | | MW: | 1900.86 | | EINECS: | | | Mol File: | 209335-49-9.mol |  |
Use
Feglymycin is an amphoteric, 13-member, linear peptide featuring 3,5-dihydroxyphenylalanine and a terminal dicarboxylate amino acid, isolated from a Streptomyces in 1999. Feglymycin is a potent antiviral agent with antibacterial activity, including against MRSA. Feglymycin specifically inhibits the enzymes MurA and MurC and inhibits cell-to-cell transfer between HIV-infected T cells, uninfected CD4+ T cells, and the DC-SIGN-mediated viral transfer to CD4+ T cells.
- Feglymycin
-
- US $3200.00 / mg
- 2025-04-28
- CAS:209335-49-9
- Min. Order:
- Purity:
- Supply Ability: 10g
|
|
209335-49-9
Recommend Suppliers |
|